Please note: This trial has finished recruiting and is not accepting new participants.
Research Center: Om Research
Location: 44125 15th Street West, Suite #203, Lancaster, CA 93534
IRB Committee: This study has been reviewed and approved by Integreview Institutional Review Board

Background

In the United States, about 1 million people have ulcerative colitis (UC). Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that affects the large intestines. It is a lifelong illness that has a significant toll on the emotional and social aspects of life. Signs and symptoms of ulcerative colitis include but are not limited to: rectal pain, rectal bleeding, the urgency to defecate, but the inability to despite the need.

Researchers are seeking new ways to help those with ulcerative colitis. Currently, there are several treatments and observational research studies being conducted for ulcerative colitis. Those experiencing flare-ups and who meet the criteria will be assigned to the treatment studies. However, those who are not experiencing active UC symptoms but still meet the criteria, will be assigned to the observational study. If a potential participant assigned to the observational study is experiencing flare-ups, they may be eligible to participate in any of the interventional (treatment) studies.

These research studies are looking for adults 18 years old or older who are diagnosed with ulcerative colitis. Participants must be willing to comply with the necessary requirements.  

Why Participate? 

• Participants may experience potential improvements to their ulcerative colitis signs and symptoms (though there’s no guarantee that (1) these investigational treatments will work, (2) that participants will receive the new potential therapy, and (3) that there will be no risks of harm).
• Participants may receive additional care and attention from the clinical trial staff for their ulcerative colitis at no cost. 
• Participants may help others who are living with ulcerative colitis in the future.
• Participants will be helping to advance medical research and knowledge.
• Participants will be compensated for time and travel participation in this study.

Your Rights

• If you decide to participate in any of these research studies and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential as described in the Informed Consent Form that participants are provided prior to participating in the study, except as required by law.
• Qualified health professionals will monitor your health as it relates to these studies.

Who Can Participate?

• Men and women aged 18 years old and older who have been diagnosed with ulcerative colitis. 
• Participants must be willing to comply with the requirements needed for any of the research studies.

Please note:

Due to the COVID-19 pandemic, the study teams would like to point out the following:

• The research site does not treat patients with/ suspected of having COVID-19.
• The research site’s waiting area is spacious enough that participants will not be in close proximity to each other.
• Hand sanitizers and handwashing areas are available at the research site.
• The research staff adheres to strict hygienic practices, including the wearing of masks and other safety measures to prevent the spread of COVID-19. 
• Any staff suspected to have COVID-19, or has come into contact with someone who has COVID-19, will automatically undergo a voluntary quarantine for 14 days.
• Interested participants will not be left waiting for a long time and will be quickly attended to. 
• Parking without cost to participants is available at the research site.